Mycophenolate Sodium
Tier C — Watch / tradeMycophenolate Sodium
Targets：IMPDH
Brand：Femulan, Mycophenolic Sodium, Myfortic
Indications (approved)：Kidney transplant rejection
Regional status
Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| MYCOS-001 | 207398-34-3 | dimethyl (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)-3-oxopentanedioate |
| MYCOS-002 | 192385-50-5 | 4-oxobut-2-yn-1-yl pivalate |
| MYCOS-003 | 207398-35-4 | methyl (E)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5-formyl-2,4-dihydroxy-6-((pivaloyloxy)methyl)benzoate |
| MYCOS-004 | 207402-09-3 | methyl (E)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5-formyl-2,4-dimethoxy-6-((pivaloyloxy)methyl)benzoate |
| MYCOS-005 | 207402-10-6 | methyl (E)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5-(hydroxymethyl)-2,4-dimethoxy-6-((pivaloyloxy)methyl)benzoate |
| MYCOS-006 | 207398-36-5 | methyl (E)-3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dimethoxy-5-methyl-6-((pivaloyloxy)methyl)benzoate |
| MYCOS-007 | 207398-37-6 | (E)-6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dimethoxy-4-methylisobenzofuran-1(3H)-one |
| MYCOS-008 | 545392-47-0 | (E)-6-(4,6-dimethoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enal |
| MYCOS-009 | 60435-90-7 | methyl (E)-6-(4,6-dimethoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
| Code | CAS No. | Intermediate |
|---|---|---|
| MYCOS-009 | 60435-90-7 | methyl (E)-6-(4,6-dimethoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
| MYCOS-010 | 53585-95-8 | methyl (E)-6-hydroxy-4-methylhex-4-enoate |
| MYCOS-011 | 126-81-8 | 5,5-dimethylcyclohexane-1,3-dione |
| MYCOS-012 | 1551042-28-4 | methyl (Z)-6-((3-chloro-3-oxopropanoyl)oxy)-4-methylhex-4-enoate |
| MYCOS-013 | 5394-63-8Available | 2,2,6-trimethyl-4H-1,3-dioxin-4-one |
| MYCOS-014 | 1551042-30-8 | methyl (Z)-6-((4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoyl)oxy)-4-methylhex-4-enoate |
| MYCOS-015 | 1551042-34-2 | methyl (Z)-6-((4-acetoxy-2-(2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetyl)-3-oxobutanoyl)oxy)-4-methylhex-4-enoate |
| MYCOS-016 | 1551041-92-9 | methyl (E)-6-(5-(acetoxymethyl)-7-hydroxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-8-yl)-4-methylhex-4-enoate |
| MYCOS-017 | 1551041-97-4 | methyl (E)-6-(5-(acetoxymethyl)-7-methoxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-8-yl)-4-methylhex-4-enoate |
| MYCOS-018 | 1551042-02-4 | methyl (E)-6-(4-hydroxy-6-methoxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
| MYCOS-019 | 1551042-06-8 | methyl (R)-4-iodo-4-((S)-4-methoxy-8-oxo-2,3,6,8-tetrahydrobenzo[2,1-b:3,4-c']difuran-2-yl)pentanoate |
| MYCOS-020 | 1551042-13-7 | methyl (R)-4-((S)-5-bromo-4-methoxy-8-oxo-2,3,6,8-tetrahydrobenzo[2,1-b:3,4-c']difuran-2-yl)-4-iodopentanoate |
Frequently asked questions
What are the approved indications of Mycophenolate Sodium?
Approved indications include: Kidney transplant rejection.
When does the Mycophenolate Sodium patent expire?
No public expiry year is available for Mycophenolate Sodium yet; this page updates once verified.
How many synthesis routes are recorded for Mycophenolate Sodium?
2 synthesis routes are recorded; the shortest is 8 steps with 92 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Mycophenolate Sodium intermediates?
1 intermediate CAS of Mycophenolate Sodium are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Mycophenolate Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04